Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
3.520
-0.100 (-2.76%)
Nov 12, 2024, 4:00 PM EST - Market closed
Mural Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 12, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 60 | 99 | - | - |
| Enterprise Value | -132 | 115 | - | - |
| Last Close Price | 3.62 | 5.92 | - | - |
| PE Ratio | - | -0.48 | - | - |
| PB Ratio | 0.30 | 0.37 | - | - |
| P/FCF Ratio | -0.33 | -0.50 | - | - |
| P/OCF Ratio | -0.33 | -0.51 | - | - |
| EV/EBITDA Ratio | 0.98 | -0.60 | - | - |
| EV/EBIT Ratio | 0.96 | -0.59 | - | - |
| EV/FCF Ratio | 1.02 | -0.58 | - | - |
| Debt / Equity Ratio | 0.05 | 0.06 | -0.90 | -1.42 |
| Debt / FCF Ratio | -0.07 | -0.08 | -0.11 | -0.16 |
| Quick Ratio | 8.38 | 9.55 | 0.04 | 0.06 |
| Current Ratio | 8.65 | 9.56 | 0.12 | 0.13 |
| Return on Equity (ROE) | -178.34% | -171.33% | - | - |
| Return on Assets (ROA) | -81.05% | -72.52% | -335.69% | - |
| Return on Capital (ROIC) | -96.64% | -87.97% | -4482.33% | - |
| Earnings Yield | -290.61% | -209.96% | - | - |
| FCF Yield | -272.15% | -200.10% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.